HCB Hospitales advances in Alzheimer’s diagnosis and treatment with new tools and innovative therapies

Alzheimer’s disease is undergoing a significant evolution, driven by the development of new biomarkers and treatments capable of targeting some of the biological mechanisms associated with the disease. In this context, HCB Hospitales continues to incorporate new diagnostic tools and prepare its healthcare pathways for therapeutic advances in the field of neurology. New diagnostic tools […]